相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
Cinzia Fionda et al.
BMC CANCER (2015)
Coordinated Expression of DNAM-1 and LFA-1 in Educated NK Cells
Monika Enqvist et al.
JOURNAL OF IMMUNOLOGY (2015)
Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in collagen-induced arthritis mouse models
Muriel Elhai et al.
JOURNAL OF INFLAMMATION-LONDON (2015)
DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
Ludovic Martinet et al.
CELL REPORTS (2015)
DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma
Ming-Ru Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma
Ping Qu et al.
HISTOPATHOLOGY (2015)
Balancing natural killer cell activation through paired receptors
Ludovic Martinet et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
Wing Leung
CLINICAL CANCER RESEARCH (2014)
Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells during Mouse Cytomegalovirus Infection
Tsukasa Nabekura et al.
IMMUNITY (2014)
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts
Natasja Nielsen et al.
IMMUNOLOGY (2014)
DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
Lucas Ferrari de Andrade et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Human NK cells and NK receptors
Francesca Bellora et al.
IMMUNOLOGY LETTERS (2014)
Recombinant soluble CD226 protein directly inhibits cancer cell proliferation in vitro
Shengke Hou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain
Shengke Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cutting Edge: DNAX Accessory Molecule 1-Deficient CD8+ T Cells Display Immunological Synapse Defects That Impair Antitumor Immunity
Kelly M. Ramsbottom et al.
JOURNAL OF IMMUNOLOGY (2014)
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
J. Chu et al.
LEUKEMIA (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
CD226 rs763361 Is Associated with the Susceptibility to Type 1 Diabetes and Greater Frequency of GAD65 Autoantibody in a Brazilian Cohort
Teresa Cristina Colvara Mattana et al.
MEDIATORS OF INFLAMMATION (2014)
Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients
Katarina M. Mirjacic Martinovic et al.
MELANOMA RESEARCH (2014)
Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
Yoko Nagumo et al.
PLOS ONE (2014)
HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain
Sebastian Bolduan et al.
VIROLOGY (2014)
Cell Transfer Therapy for Cancer: Past, Present, and Future
Xiaoling Qian et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells
J. Ludovic Croxford et al.
BLOOD (2013)
Promoting regulation via the inhibition of DNAM-1 after transplantation
Motoko Koyama et al.
BLOOD (2013)
MicroRNA function in NK-cell biology
Aimee M. Beaulieu et al.
IMMUNOLOGICAL REVIEWS (2013)
The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the AIR-mediated DNA damage response pathway
Lia Vassena et al.
JOURNAL OF GENERAL VIROLOGY (2013)
The CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in Humans
Ester Lozano et al.
JOURNAL OF IMMUNOLOGY (2013)
Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
Ilona Hromadnikova et al.
MEDIATORS OF INFLAMMATION (2013)
Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells
Neha Kamran et al.
PLOS ONE (2013)
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection
Joachim Koch et al.
TRENDS IN IMMUNOLOGY (2013)
Natural killer cells in human autoimmune disorders
Leslie A. Fogel et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
Alessandra Soriani et al.
ONCOIMMUNOLOGY (2013)
Retargeting NK-92 cells by means of CD19-and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
Laurent Boissel et al.
ONCOIMMUNOLOGY (2013)
Crystal Structure of Cell Adhesion Molecule Nectin-2/CD112 and Its Binding to Immune Receptor DNAM-1/CD226
Jun Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Interferon α-Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
Kerstin A. Stegmann et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR
Giulia Matusali et al.
JOURNAL OF VIROLOGY (2012)
Complementary Phosphorylation Sites in the Adaptor Protein SLP-76 Promote Synergistic Activation of Natural Killer Cells
Hun Sik Kim et al.
SCIENCE SIGNALING (2012)
Identification and Functional Analysis of Ligands for Natural Killer Cell Activating Receptors in Colon Carcinoma
Zhang Zhang et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2012)
CD8 T cell defect of TNF-α, and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection
Megan J. Welch et al.
VIROLOGY (2012)
Tumor microenvironment in NSCLC suppresses NK cells function
Isabelle Cremer et al.
ONCOIMMUNOLOGY (2012)
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies
Giuliana Magri et al.
BLOOD (2011)
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction
Michele Ardolino et al.
BLOOD (2011)
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function
Ardiana Moustaki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy
Giulia Fregni et al.
CLINICAL CANCER RESEARCH (2011)
The Role of Natural Killer Cells in Sepsis
Laurent Chiche et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions
Sara Morgado et al.
JOURNAL OF INNATE IMMUNITY (2011)
Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
Erica B. Wilson et al.
PLOS ONE (2011)
Reply to Seth et al.: DNAX accessory molecule-1 (DNAM-1) plays an important role in alloreactive CD8+ T cells responsible for the exacerbation of acute graft-versus-host disease
Tsukasa Nabekura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Association of the CD226 single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han population
Y. Du et al.
TISSUE ANTIGENS (2011)
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection
Marina Cella et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Synergistic Signals for Natural Cytotoxicity Are Required to Overcome Inhibition by c-Cbl Ubiquitin Ligase
Hun Sik Kim et al.
IMMUNITY (2010)
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112
Virginie Prod'homme et al.
JOURNAL OF GENERAL VIROLOGY (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
Alessandra Soriani et al.
BLOOD (2009)
Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients
Zhuwei Xu et al.
BMC IMMUNOLOGY (2009)
The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent Ex vivo Natural Killer Cell Activation and Maturation
Claudia Penafuerte et al.
CANCER RESEARCH (2009)
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30
Mirna Balsamo et al.
EXPERIMENTAL HEMATOLOGY (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Molecular cloning, characterization and three-dimensional modeling of porcine nectin-2/CD112
Lu Wang et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer
Sonja Textor et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
Dirk H. J. Verhoeven et al.
MOLECULAR IMMUNOLOGY (2008)
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Mattias Carlsten et al.
CANCER RESEARCH (2007)
The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing
Isabel Y. Pappworth et al.
JOURNAL OF VIROLOGY (2007)
Human NK cell education by inhibitory receptors for MHC class I
Nicolas Anfossi et al.
IMMUNITY (2006)
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system
Deren Huang et al.
FASEB JOURNAL (2006)
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction
D Pende et al.
BLOOD (2006)
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
S Tahara-Hanaoka et al.
BLOOD (2006)
NKG2D-mediated activation of cytotoxic lymphocytes: Unique signaling pathways and distinct functional outcomes
Jadee L. Upshaw et al.
SEMINARS IN IMMUNOLOGY (2006)
Natural-killer cells and dendritic cells: l' union fait la force
T Walzer et al.
BLOOD (2005)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
D Pende et al.
BLOOD (2005)
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141
P Tomasec et al.
NATURE IMMUNOLOGY (2005)
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis
D Pende et al.
MOLECULAR IMMUNOLOGY (2005)
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
L Moretta et al.
EMBO JOURNAL (2004)
The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large
KJ Ralston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction
R Castriconi et al.
CANCER RESEARCH (2004)
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
KE Sloan et al.
BMC CANCER (2004)
DNAM-1 and PVR regulate monocyte migration through endothelial junctions
N Reymond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation
K Shibuya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
What does it take to make a natural killer?
F Colucci et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
分享论文
